{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:34:15Z","timestamp":1763001255011,"version":"3.45.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ahjo.2024.100369","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T11:53:55Z","timestamp":1706874835000},"page":"100369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation"],"prefix":"10.1016","volume":"39","author":[{"given":"Xuemei","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amol D.","family":"Dhamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominick","family":"Latremouille-Viau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Centers for Disease Control and Prevention","key":"10.1016\/j.ahjo.2024.100369_bb0005"},{"issue":"10","key":"10.1016\/j.ahjo.2024.100369_bb0010","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics\u20142019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ahjo.2024.100369_bb0015","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ahjo.2024.100369_bb0020","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics\u20142021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ahjo.2024.100369_bb0025","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","article-title":"Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study","volume":"147","author":"Wolf","year":"1987","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.ahjo.2024.100369_bb0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ahjo.2024.100369_bb0035","first-page":"e1","article-title":"Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation","volume":"22","author":"Kachroo","year":"2016","journal-title":"Am. J. Manag. Care"},{"issue":"12","key":"10.1016\/j.ahjo.2024.100369_bb0040","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1161\/STROKEAHA.118.020232","article-title":"Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients: the ARISTOPHANES study","volume":"49","author":"Lip","year":"2018","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.ahjo.2024.100369_bb0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ahjo.2024.100369_bb0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14234","article-title":"Disparities in anticoagulant therapy initiation for incident atrial fibrillation by race\/ethnicity among patients in the Veterans Health Administration system","volume":"4","author":"Essien","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"35","key":"10.1016\/j.ahjo.2024.100369_bb0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029997","article-title":"Impact of social determinants of health on anticoagulant use among patients with atrial fibrillation: systemic review and meta-analysis","volume":"101","author":"Khatib","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.ahjo.2024.100369_bb0060","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jamacardio.2016.1025","article-title":"Racial differences in atrial fibrillation-related cardiovascular disease and mortality: the Atherosclerosis Risk in Communities (ARIC) study","volume":"1","author":"Magnani","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ahjo.2024.100369_bb0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.amjcard.2021.05.008","article-title":"Meta-analysis of racial disparity in utilization of oral anticoagulation for stroke prevention in atrial fibrillation","volume":"153","author":"Shahid","year":"2021","journal-title":"Am. J. Cardiol."},{"issue":"12 Suppl","key":"10.1016\/j.ahjo.2024.100369_bb0070","article-title":"Racial and ethnic differences in the management of atrial fibrillation","volume":"3","author":"Tamirisa","year":"2021","journal-title":"CJC Open"},{"issue":"5","key":"10.1016\/j.ahjo.2024.100369_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104718","article-title":"Racial disparity in the prescription of anticoagulants and risk of stroke and bleeding in atrial fibrillation patients","volume":"29","author":"Tedla","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ahjo.2024.100369_bb0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ahj.2020.07.012","volume":"229","author":"Al-Khatib","year":"2020","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ahjo.2024.100369_bb0085","article-title":"Underutilization of oral anticoagulant therapy among elderly patients with atrial fibrillation: insights from the United States medicare database","volume":"77(18_Supplement_1):1641","author":"Munir","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ahjo.2024.100369_bb0090","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1377\/hlthaff.2021.00036","article-title":"Quantifying the economic burden of drug utilization management on payers, manufacturers, physicians, and patients: study examines the economic burden of drug utilization management on payers, manufacturers, physicians, and patients","volume":"40","author":"Howell","year":"2021","journal-title":"Health Aff."},{"author":"American College of Cardiology","key":"10.1016\/j.ahjo.2024.100369_bb0095"},{"issue":"11","key":"10.1016\/j.ahjo.2024.100369_bb0100","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"issue":"2","key":"10.1016\/j.ahjo.2024.100369_bb0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ahjo.2024.100369_bb0110","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.ahjo.2024.100369_bb0115","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011427","article-title":"Trajectories of oral anticoagulation adherence among Medicare beneficiaries newly diagnosed with atrial fibrillation","volume":"8","author":"Hernandez","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ahjo.2024.100369_bb0120","article-title":"T. Identifying prescribing differences of direct oral anticoagulants for atrial fibrillation within the Military Health System. American Heart Journal Plus","volume":"26","author":"Hirschfeld","year":"2023","journal-title":"Cardiol. Res. Pract."},{"issue":"11","key":"10.1016\/j.ahjo.2024.100369_bb0125","first-page":"1468","article-title":"Racial disparities in medication use: imperatives for managed care pharmacy","volume":"26","author":"Kogut","year":"2020","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"6","key":"10.1016\/j.ahjo.2024.100369_bb0130","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s11606-008-0561-9","article-title":"Differences in the patterns of health care system distrust between blacks and whites","volume":"23","author":"Armstrong","year":"2008","journal-title":"J. Gen. Intern. Med."},{"issue":"6","key":"10.1016\/j.ahjo.2024.100369_bb0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1525-1497.2006.00453.x","article-title":"Racial differences in attitudes toward innovative medical technology","volume":"21","author":"Groeneveld","year":"2006","journal-title":"J. Gen. Intern. Med."},{"issue":"18","key":"10.1016\/j.ahjo.2024.100369_bb0140","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1161\/CIRCULATIONAHA.108.825133","article-title":"Differences in specialist consultations for cardiovascular disease by race, ethnicity, gender, insurance status, and site of primary care","volume":"119","author":"Cook","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ahjo.2024.100369_bb0145","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/jama.2016.11237","article-title":"The high cost of prescription drugs in the United States: origins and prospects for reform","volume":"316","author":"Kesselheim","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ahjo.2024.100369_bb0150","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s11606-021-06937-9","article-title":"Association between high deductible health plans and cost-related non-adherence to medications among Americans with diabetes: an observational study","volume":"37","author":"Rastas","year":"2022","journal-title":"J. Gen. Intern. Med."},{"issue":"18","key":"10.1016\/j.ahjo.2024.100369_bb0155","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahjo.2024.100369_bb0160","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0107","article-title":"Outcomes associated with Oral anticoagulants plus antiplatelets in patients with newly diagnosed atrial fibrillation","volume":"3","author":"Fox","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"22","key":"10.1016\/j.ahjo.2024.100369_bb0165","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ahjo.2024.100369_bb0170","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/CIRCULATIONAHA.113.002927","article-title":"Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry","volume":"128","author":"Steinberg","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahjo.2024.100369_bb0175","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"Kumbhani","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ahjo.2024.100369_bb0180","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/joim.12588","article-title":"Management of acute ischaemic stroke in patients with dementia","volume":"281","author":"Subic","year":"2017","journal-title":"J. Intern. Med."}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602224000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602224000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:31:22Z","timestamp":1763001082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602224000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":36,"alternative-id":["S2666602224000120"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2024.100369","relation":{},"ISSN":["2666-6022"],"issn-type":[{"type":"print","value":"2666-6022"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2024.100369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100369"}}